Provided by Tiger Fintech (Singapore) Pte. Ltd.

Guardant Health Inc.

50.86
+0.83001.66%
Post-market: 51.470.6130+1.21%19:46 EDT
Volume:3.37M
Turnover:172.15M
Market Cap:6.30B
PE:-15.05
High:53.42
Open:50.13
Low:49.57
Close:50.03
Loading ...

Why GH Research PLC (GHRS) Is Skyrocketing So Far In 2025

Insider Monkey
·
04 Feb

GH Research Launches $150 Million Public Offering

MT Newswires Live
·
04 Feb

GH Research Initiates $150 Million Public Offering to Advance Depression Treatment

TIPRANKS
·
04 Feb

GH Research announces $150M ordinary shares offering

TIPRANKS
·
04 Feb

GH Research Announces Proposed Public Offering

GlobeNewswire
·
04 Feb

JMP Securities Reaffirms Their Buy Rating on GH Research (GHRS)

TIPRANKS
·
04 Feb

GH Research Shares Jump After Positive Phase 2B Trial Results

Dow Jones
·
03 Feb

GH Research’s GH001 Shows Promising Results in TRD Phase 2b Trial

TIPRANKS
·
03 Feb

GH Research Shares Soar 90% Pre-Bell After Trial of GH001 to Treat Depression Meets All Endpoints

MT Newswires Live
·
03 Feb

GH Research announces primary endpoint met in Phase 2b trial of GH001

TIPRANKS
·
03 Feb

GH Research Announces Primary Endpoint Met in Phase 2b Trial with GH001 in TRD Demonstrating -15.5 Point Placebo-adjusted MADRS Reduction

GlobeNewswire
·
03 Feb

Why Guardant Health, Inc. (GH) Is Among the Best Booming Stocks to Invest in Now?

Insider Monkey
·
03 Feb

GH Research Shares Rise Ahead of Release of Clinical-Trial Results

Dow Jones
·
01 Feb

GH Research to Update on Promising TRD Treatment Trial

TIPRANKS
·
01 Feb

GH Research to Provide Update on Phase 2b Trial with GH001 in TRD

GlobeNewswire
·
01 Feb

Guardant Health Selected by Abu Dhabi Health Department to Launch Colorectal Cancer Screening Program

MT Newswires Live
·
30 Jan

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks
·
30 Jan

These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar

Zacks
·
28 Jan

GH Research Price Target Maintained With a $40.00/Share by HC Wainwright & Co.

Dow Jones
·
27 Jan

Analysts Offer Insights on Healthcare Companies: Demant (OtherWILLF) and Guardant Health (GH)

TIPRANKS
·
26 Jan